Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer
Most Cited Paper
in Hepatocellular Carcinoma Treatment and Prognosis
18 Months Post-Publication
Class of 2026
“Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/hepatocellular-carcinoma-treatment-and-prognosis/2026/
Topics
Hepatocellular carcinoma · intra-tumor heterogeneity · inter-tumor heterogeneity · Patient-derived organoid · Organoid biobank · pharmacogenomic profiling · drug sensitivity screening · Precision medicine · lenvatinib resistance · c-Jun · JNK signaling · Wnt/β-catenin signaling pathway · multi-gene expression signatures · patient stratification · genomic landscape · transcriptomic characteristics · Hepatocellular carcinoma · Combination therapy · veratramine · PKUF-01 · Drug synergy · Predictive biomarker · drug response prediction · histopathology recapitulation · Patient-derived organoid · biomarker panels · tumor heterogeneity landscape · clinically relevant drugs · In vivo models · c-Jun inhibitor
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Hepatocellular Carcinoma Treatment and Prognosis Papers, Class of 2026. https://pri.pepkio.com/top-papers/hepatocellular-carcinoma-treatment-and-prognosis/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459